MedPath
NMPA Approval

Insulin Lispro Injection

国药准字S20194000

November 16, 2020

国药准字S20194000

Drug Information

赖脯胰岛素注射液

速秀霖

注射剂

3ml:300单位(预填充注射笔)

生物制品

November 16, 2020

Company Information

Applicant Company

北京市通州区漷县镇南凤西一路8号

Manufacturing Company

北京市通州区漷县镇南凤西一路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

赖脯胰岛素注射液 - NMPA 批准文号 | MedPath